| 吴少华 安维新 李小姣.“整合疗法”综合治疗脂肪肝的临床探讨[J].实用中西医结合临床,2009,(3):13-15 |
| “整合疗法”综合治疗脂肪肝的临床探讨 |
|
| |
| DOI： |
| 中文关键词: 整合疗法 脂肪肝 HD肝病治疗仪 |
| 英文关键词: integration therapy fatty liver HD liver disease therapy instrument |
| 基金项目: |
|
| 摘要点击次数: 587 |
| 全文下载次数: 239 |
| 中文摘要: |
| 目的：探讨应用HD肝病治疗仪中药导入配合运动疗法、饮食疗法有机“整合”综合治疗脂肪肝的临床疗效及不良反应。方法：采用随机对照研究方法，治疗组采用HD-91-Ⅱ型肝病治疗仪物理治疗和中药穴位透入配合运动疗法、饮食疗法有机“整合”综合治疗；对照组采用降脂药物血脂康加凯西莱片口服治疗，均20d为1个疗程。结果：治疗组在症状和体征改善方面优于对照组；治疗组ALT治疗后下降优于对照组（P <0.01）；治疗前后血脂比较，治疗组TC和TG均显著下降，两组治疗后血脂比较，有显著性差异；治疗组与对照组临床总有效率分别是90%和70%，治疗组明显优于对照组。治疗组在治疗过程中未发生1例不良反应。结论：采用“整合疗法”综合治疗脂肪肝，效果较满意，可以代替药物治疗，值得临床推广。 |
| 英文摘要: |
| Objective:To observe the clinical efficacy of HD liver Disease therapy instrument and its side effects in the treatment of fatty liver,combined with the movement therapeutics.Methods:The patients were randomized into the therapy group and the control group.The therapy group received HD-91-II liver disease therapy instrument combined with the point penetration of traditional Chinese medicine,food therapeutics and movement therapeutics in the treatment. The control group received XueZhiKang Capsule and Tiopronin.The treatment duration of both groups lasted 20 days as one period of theatment.Results:The therapy group have advantages over the control group in the sympyom and physicai function. The rates for ALT of the therapy group decreased better than that of the control group(P <0.01).TC and TG of the therapy group decreased significantiy in comparison of the blood fat in the pre-test and the test after the treatment(P <0.01). Total effective rate was 90% in the treatment group and 70% in control group. The former was obviousiy better than latter. conclusion:The integration therapy on the treatment of fatty liver has satisfying clinical efficacy so that we wish to promote it widely. |
|
查看全文
查看/发表评论 下载PDF阅读器 |
| 关闭 |
